Tag: Nintedanib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Nintedanib

Europe Idiopathic Pulmonary Fibrosis Market Report 2022: Featuring Key Players GNI ...

Added to Collection on: 2022-08-11 09:31:25

Tags for this article:

Medicine
Medical specialties
Clinical medicine
Breakthrough therapy
RTT
Idiopathic pulmonary fibrosis
Pirfenidone
Pulmonary fibrosis
Nintedanib
Pulmonary rehabilitation
IPF
Lung transplantation

Click the tags to see associated articles and topics

View Article Details
Saracatinib as Effective, or Superior to Ofev, Esbriet in IPF Models: Study - Pulmonary Fibrosis News

Added to Collection on: 2022-08-30 18:55:24

Tags for this article:

Medicine
Medical specialties
Health
Breakthrough therapy
RTT
Idiopathic pulmonary fibrosis
Nintedanib
Pirfenidone
Pulmonary fibrosis
IPF
Fibrosis
Interstitial lung disease
Esbriet
United States
saracatinib
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Idiopathic Pulmonary Fibrosis Disease Treatment Market Demanding Factors 2022 - Spooool.ie

Added to Collection on: 2022-09-19 03:50:41

Tags for this article:

Breakthrough therapy
RTT
Chemical compounds
Organic compounds
Genentech
Pirfenidone
Health
Pulmonary fibrosis
Idiopathic pulmonary fibrosis
Nintedanib
Galecto Biotech

Click the tags to see associated articles and topics

View Article Details
Alentis Receives FDA Orphan Drug Designation for Lixudebart to Treat Idiopathic Pulmonary Fibrosis

Added to Collection on: 2024-05-29 11:35:35

Tags for this article:

Idiopathic pulmonary fibrosis
Fibrosis
Orphan drugs
IPF
Setanaxib
Nintedanib
Switzerland
Basel

Click the tags to see associated articles and topics

View Article Details
Interstitial Lung Disease Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies ...

Added to Collection on: 2024-07-09 11:26:46

Tags for this article:

Lung disorders
ATyr Pharma
Interstitial lung disease
Boehringer Ingelheim
Nintedanib
AstraZeneca
Interstitial
Bristol-Myers Squibb
Lung cancer
Roche
United Therapeutics
Regend Therapeutics
Avalyn Pharmaceuticals
HEC Pharm
Bayer
Interstitial Lung Disease Companies
FibroGen
puretech health
Prometheus Biosciences
Genentech
Avalyn Pharma
Reata Pharmaceuticals
aTyr Pharma Inc.
AdAlta
Taiho Pharmaceutical
CSL Behring
Bristol-Myers Squibb

Click the tags to see associated articles and topics

View Article Details
Insilico announces positive topline results for IPF treatment - Longevity.Technology

Added to Collection on: 2024-11-12 20:12:35

Tags for this article:

Idiopathic pulmonary fibrosis
Lung disorders
Orphan drugs
Pulmonary fibrosis
IPF
Monoclonal antibodies
Nintedanib
Pneumonia
Simtuzumab
Insilico Medicine

Click the tags to see associated articles and topics

View Article Details
Novel, AI-Procured ISM001-055 Demonstrates Great Promise for Treatment of IPF

Added to Collection on: 2024-11-12 17:36:25

Tags for this article:

Idiopathic pulmonary fibrosis
Lung disorders
Orphan drugs
Pulmonary fibrosis
Insilico Medicine
IPF
Nintedanib
Setanaxib

Click the tags to see associated articles and topics

View Article Details
Interstitial Lung Disease (ILD) Treatment Market to Reach USD 3.22 Bn by 2034

Added to Collection on: 2024-11-28 16:06:21

Tags for this article:

Lung disorders
Orphan drugs
Interstitial lung disease
Idiopathic pulmonary fibrosis
Nintedanib
Pirfenidone
Pulmonary fibrosis
Boehringer Ingelheim
Acute interstitial pneumonitis
High-resolution computed tomography
Lung cancer
Roche

Click the tags to see associated articles and topics

View Article Details
Boehringer's nerandomilast shows promise in phase 3 pulmonary fibrosis study - PMLiVE

Added to Collection on: 2025-02-12 12:47:08

Tags for this article:

Lung disorders
Idiopathic pulmonary fibrosis
Interstitial lung disease
Pulmonary fibrosis
IPF
Shortness of breath
Nintedanib
Admilparant
Boehringer Ingelheim

Click the tags to see associated articles and topics

View Article Details
More Results for Nerandomilast Reported by BI, This Time for Progressive Pulmonary Fibrosis

Added to Collection on: 2025-02-15 13:36:38

Tags for this article:

Lung disorders
Orphan drugs
Pulmonary fibrosis
Interstitial lung disease
Idiopathic pulmonary fibrosis
Boehringer Ingelheim
PDE4 inhibitor
Phosphodiesterase 4
Fibrosis
Nintedanib
Pirfenidone

Click the tags to see associated articles and topics

View Article Details